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Abstract. This case of a Merkel cell carcinoma is unusual 
due to the occurrence of the tumor on the thigh; most 
Merkel cell tumors have been found on the sun-exposed 
region of the head and neck. Histologically, the nodule 
was composed of sheets of uniform, poorly differentiated 
cells with a high nuclear to cytoplasmic ratio. Electron 
miscroscopy revealed perinuclear filaments, scattered 
dense core granules, and complex, interdigitating 
processes within cytoplasmic membranes. Treatment 
consisted of surgical excision of the tumor with a wide 
margin. 
INTRODUCTION 
We report a case of Merkel cell carcinoma,'l2 also 
known as primary neuroendocrine carcinoma of the 
skin,3 located on a nonsun-exposed area of the 
thigh. Treatment consisted of surgical excision with 
a wide margin. After 3 years of follow-up, there is 
no evidence of tumor recurrence. 
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CASE REPORT 
A 71-year-old Latin American man presented with 
a 2-month history of a nodule on the left medial 
thigh, first noted as a "purple spot" which soon 
enlarged and became intermittently painful when 
exposed to cold. There was no history af previous 
skin conditions. Past medical history was remark- 
able for noninsulin-dependent diabetes mellitus, 
hypertension, and a history of smoking (100 packs 
per year). 
Physical examination of the skin revealed a soli- 
tary, firm, shiny, violaceous, dome-shaped nodule 
measuring 2.6 x 2.3 cm on a papillomatous base, 
surrounded by a poorly demarcated, mottled, 
brownish-red patch measuring 8.0 x 8.5 cm rep- 
resenting an area of contact irritant dermatitis due 
to a previous dressing (Fig. 1). No lymphadenop- 
athy was detected, and the remainder of the 
physical examination was unremarkable. Clinical 
differential diagnoses included adnexal tumors, 
melanoma, lymphoma, and metastatic carcinoma. 
Laboratory and radiologic evaluation showed no 
evidence of metastatic disease. Chest x-ray revealed 
two areas of increased density in the left upper lung 
field, clinically unchanged from previous studies 
and believed to represent stable granulomatous 
change. 
Histopathologic evaluation of the skin showed 
focal hyperpigmentation of the basal layer but 
otherwise a normal epidermis. The superficial and 
deep dermis contained a diffuse infiltrate composed 
of uniform, round atypical cells with enlarged nu- 
clei (Figs. 2 and 3). In some areas, the atypical cells 
formed cohesive nests, whereas in other areas, they 
were prominently discohesive. Focally, there was a 
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cords of round uniform cells. 
suggestion of trabecular formation. Mitoses were 
not conspicuous (Fig. 4). The histologic differential 
diagnoses included malignant melanoma, adnexal 
tumors, neuroblastoma, lymphoma, and metastatic 
oat cell carcinoma. Special stains for chloracetate 
esterase, metachromatic granules, and pan leuko- 
cyte antigen were all negative. Tests for neuron- 
specific enolase and monoclonal antibodies for 
cytokeratin were not performed. 
Ultrastructural analysis of the lesion revealed 
atypical cells with oval nuclei showing focal inden- 
tations and evenly dispersed chromatin. Of note, 
there were perinuclear filaments with focal aggre- 
gation (Fig. 5). Within the cytoplasm one found, in 
addition to mitochondria and golgi, scattered dense 
core granules. Cytoplasmic membranes showed 
complex interdigitating processes (Fig. 6) .  There 
were no myeloid or Birbeck granules, melano- 
somes, or mast cell granules seen. These findings 
FIGURE 3. (Mid power) dense deeply invasive cords and 
nests of cells with hyperchromatic rounded nuclei with 
scant cytoplasm. 
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were determined to Ge compatible with Merkel c k  
Carcinoma, also known as primary ne~roendocrine 
carcinoma of the skin. 
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FIGURE 5. Electron microscopy of malignant cell with in- 
dented nucleus, perinuclear cytoplasmic filaments and 
rare membrane bound dense core granules. 
FIGURE 4. (High power) evenly dispersed heterochro- 
matin; inconspicuous nucleoli. 
DISCUSSION 
Because of the similarities both histologically and 
ultrastructurally between Merkel cell tumors and 
metastatic oat cell carcinoma, several authors em- 
phasize that all three features, namely, dense core 
granules, perinuclear filaments, and interdigitating 
processes be present before making the diagnosis 
of Merkel cell ca r~ inoma .~  Other authors have been 
unable to find consistent, reliable, distinguishing 
features ultrastructurally between Merkel cell and 
oat cell carcinoma and stress the importance of 
thorough evaluation for occult malignancy before 
making the diagnosis of Merkel cell car~ inoma.~  
Ultrastructural analysis is also necessary to separate 
Merkel cell tumor from squamous cell carcinoma 
(poorly differentiated), malignant melanoma, his- 
tiocytosis X, and adnexal tumors (Table 1). 
Treatment of the tumor consisted of surgical ex- 
cision with a wide margin. After 3 years of follow- 
up, there is no evidence of tumor recurrence. Had 
examination of the patient revealed lymphadenop- 
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FIGURE 6. Electron microscopic appearance of elongated 
interdigitating spinous cytoplasmic processes containing 
several membrane bound dense core granules. 
athy, local nodal resection and postoperative radia- 
tion therapy would have been considered. 
Treatment of Merkel cell carcinoma is con trover- 
sial and published studies are difficult to interpret 
because of the limited follow-up and variation in 
the modes of treatment used. Postexcision, approx- 
imately 25-65% of patients develop local or lym- 
phatic metastases, depending on the series, and 
20% die as a result of their d i ~ e a s e . ~ ' ~ *  Recurrences 
are felt to be related to the presence of tumor close 
to the surgical margin. Thus, several authors em- 
phasize the need for at least a 2 mm microscopic 
tumor-free margin in the primary excision." 
Stawowy proposes the following guidelines in 
the management of Merkel cell carcinoma: thor- 
ough clinical evaluation to detect the presence of 
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metastatic disease, wide excision of tumor, post- 
operative local radiation therapy in selected cases, 
and regular follow-up. In the absence of lymph- 
adenopathy, "the pathological examination of the 
primary tumor serves as parameter for the need for 
lymph node biopsy. If the primary tumor is larger 
than 2 cm, contains 10 or greater mitoses per high- 
power-field, demonstrates evidence of lymphatic 
invasion or is composed of the small cell variant, 
a partial regional node dissection is recom- 
mended."" The presence of lymphadenopathy 
makes lymph node biopsy mandatory. Should 
nodes prove to be positive, a radical lymph node 
dissection followed by radiotherapy and/or chemo- 
therapy is recommended. In general, chemother- 
apy, consisting of Doxirubicin alone or in combi- 
nation with cyclophosphamide or imidazole 
carboxamide, is recommended if the tumor is not 
resectable, is metastatic, is of the small cell variant, 
or if greater than 30% of the node is replaced by 
tumor." 
Roenigk et al. emphasize the need for preopera- 
tive diagnosis using both formalin-fixed and elec- 
tron microscopic techniques before proceeding with 
definitive excision. Frozen tissue technique, em- 
ployed in microscopically controlled excisional sur- 
gery, was considered inadequate for the diagnosis 
of Merkel cell carcinoma and thereby also in the 
evaluation of surgical margins.'* 
Of the over 100 cases of Merkel cell tumor de- 
scribed so far, the case presented here is moder- 
ately unusual as  far as its location on the body. 
Whereas most Merkel cell tumors have been found 
on the head and neck in sun-exposed areas, this 
patient's tumor was lacated on the thigh in a non- 
sun-exposed site. In one series, 3 of 37 cases pre- 
sented on the thigh.6 In all other respects, this pa- 
tient's profile reflects that found in the literature for 
Merkel cell carcinoma, namely, late age of onset, 
rapid growth rate, and the histologic and ultra- 
structural features described above. Risk factors for 
this tumor have included sun exposure7 and ad- 
vanced age. Males have an increased risk of devel- 
oping this tumor.5 
O'Rourke tecently reported a cake of Merkel cell 
carcinoma that, after undergoing local metastasis, 
regressed spontaneously. This was felt to be the 
result of a cell-mediated immune phenomenon.8 
Hoefler et al. demonstrated the presence in Mer- 
kel cell tumors of neuron specific enolase, cyto- 
keratin, and neurofilament protein by immuno- 
histochemical  technique^.^ Not only may these 
techniques aid in the differential diagnosis (Table 
2), but they may also point to the cell origin for 
these tumors. Based on early studies using these 
techniques, the Merkel cell tumors may be more 
closely related to neuroendocrine cells than to epi- 
dermal Merkel cells because of their resemblance 
morphologically to enteroendocrine cells of the 
small intestine, their location in the dermis and 
subcutis, and the absence in these tumors of vaso- 
active intestinal polypeptide (VIP) and meten- 
TABLE 1 
Ultrastructural Features Important in the Diagnosis of Merkel Cell Tumors 
Langerhans Dense Core 
Granules Glycogen Granules Desmosomes Tonofilaments Melanosomes 
- - - - Squamous Cell Carcinoma + + 
Malignant Melanoma - - 
Histiocytosis X - - - 
Lymphoma - - - - 
- - - + 
- - + 
- + Adnexal Tumor - - - 
Oat Cell Carcinoma 





- - - - - 
- - - - - 
TABLE 2 
Immunohistochemical Features Important in the Diagnosis of Merkel Cell Tumors 
Neuron Specific 
Enolase Neurofilament Protein Keratin Antigens S 100 Protein 
Malignant Melanoma - 
Lymphoma - 
Neuroblastoma + 
Adnexal Tumor - 
Merkel Cell Tumor + 
(From Hoefler et al, 1984) 
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cephalon, two markers for Merkel cells.*0 
In summary, Merkel cell tumor of the skin is a 
relatively rare neoplasm with a potentially aggres- 
sive behavior. Early diagnosis using electron mi- 
croscopy, light microscopy, and immunohisto- 
chemical techniques are useful in establishing a 
diagnosis of Merkel cell tumor. Merkel cell tumor 
should be considered in the differential diagnosis 












not they appear on sun-exposed surfaces. 
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Development of Neuroendocrine (Merkel cell) 
Carcinoma Mixed with Squamous Cell Carcinoma 
in Erythema Ab Igne. CS Jones, SK Tyring, PC 
Lee, J-D Fine. Arch Dermatol 124:llO-113, 1988. 
The authors report a patient with co-existing inva- 
sive squamous cell carcinoma and Merkel cell car- 
cinoma (MCC), superimposed upon erythema ab 
igne of the leg. Routine histopathologic diagnosis 
was confirmed by antibody studies for cytokeratin 
and neuron specific enolase and by electron mi- 
croscopy. Previous studies have reported a 34% 
concurrence rate for SCC and MCC. Some expla- 
nations have been offered to explain this co-exist- 
ence: (1) A common precursor cell shows differen- 
tiation towards both keratinocytes and endocrine 
cells, or (2) the precursor cells of each neoplasm are 
affected by the same carcinogen and thus two tu- 
mors arise and co-exist. 
Superpulse COz Laser Treatment of Facial Syrin- 
gomata. DB Apfelberg, JR Maser, H Lash, DN 
White, B Cosman. Laser Surg Med 7:533-537,1987. 
Eight patients were treated as outpatients under lo- 
cal anesthesia. Previous treatment with continuous 
wave CO, lasers had been unsuccessful. A vapor- 
izing mode was used. Once the overlying epidermis 
was removed, fine forceps were used to extricate 
the underlying cyst. The wounds usually healed in 
7-10 days although fading required 6-8 weeks. Five 
of six patients had good to excellent results; the 
remaining patient did not improve. Recurrences 
were uncommon. AIthough previous authors have 
reported good results with the continuous wave 
CO, laser, these authors suggest that the super- 
pulsed CO, laser may be more effective and may 
cause less scarring because of the tissue vibration 
it  creates and because less thermal damage occurs. 
PEARON G.  LANG, J K . ,  M.D. 
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ADVANCED FORMULA 
EXTENDING YOUR LIMITS IN 
THERAPY 
HIGH-POTENCY CORTICOSTEROID 
(potency expressed as betamethasone) 
For Dermatologlc Us. Only-Not for Ophthalmic Use 
Summary of Prorcrlblng Idornutlon 
INDlCAllONS AND UZAGE DIPROLENE AF Cream is indicated for relief 
of the inflammatory and pruritic manifestations of corricosteroid-responsive 
dermatoses 
CONTRAINDICATIONS DIPROLENE AF Cream is contraindicared in patients 
who are hypersensitive to betamethasone dipropionate to Other corticosteroids 
or to any ingredient in this preparation 
PRECAUTIONS General Systemic absorption of topical corticosteroids has 
produced reversible HPA axis suppression manifestattons of Cushings syndrome 
tiyperglycemla and glucosurir in some patients 
Conditions which augment systemic absorption include the application of the 
more potent ~ ~ r t i ~ ~ ~ l e r ~ i d ~  use over large surface areas prolon ed use and the 
addition of occlusive dressings (See DOSAGE AND ADMlNliTRATION 
section I 
axis suppression is rioted an attempt should be made to withdraw the drug to 
reduce the frequency of application or to substitute a less potent steroid 
Recovefy of HPA ax6 function 18 generally prompr and complete upon 
di5continuation of the drug Infrequently signs and symptoms of steroid 
withdrawal may occur requiring supplemental sysremic corticosteroids 
Children may absorb proportionally larger amounts of topical corticosreroids 
and thus be more susceptible to systemic toxicity (See PRECAUTIONS- 
Pedlatrlt Use J 
If irritation develops topical corticosteroids should be discontinued and 
appropriate therapy instituted 
In the presence of dermatologlcal infections the use of an appropriate 
mtifungdl or antibacterial agent should be instituted I f  a favorable response does 
not occur promptly the corticosteroid should be discontinued until the infection 
has been adequately controlled 
Laboratory Tmsts The following tests may be helpful in evaluating HPA axis 
suppression Urinary free cortisol test ACTH stimulation test 
Cardnogcnesb, Mut890nOSlS. and Impalrment of fortlllty Long- 
term animal studies have not been performed to evaluate the carcinogenic 
potential or the effect on fertility of topically applied corticosteroids 
Studies to determine mutagenicity with prednisolone and hydrocortisone have 
revealed negative results 
Pregnancy Catogory C Corticosleroids are generally [eratogenic in 
laboratory animals when administered systemically at relatively low dosage levels 
The mole potent corricosteroids have been shown to be reratogenic after dermal 
application in laboratory animals There are no adequate and well-controlled 
Studies of the teratoaenic effects of tooicallv anolied corticosteroids in oreonant 
prolonged periods of time 
Nurslng Mothers It is not known whether to~ical administration of 
1 orricosrer~ds can resuit in sufficienr systemic absorption to produce detectable 
quantities in breast milk Systemically administered corricosteroids are secreted into 
breasr milk in quantities not likely to have a deleterious effect on the infant 
Nevertheless a decision should be made whether to discontinue nursing or to 
iiiscontinue the drug taking into account the importance of the drug to the 
mother 
recommended 
Podlatrlc Use Use of DIPROLENE AF Cream in children under I2  years is not 
yrowth retdrdation delayed weight gain low plasma corrisol levels and absence 
of rexponse to ACTH stimulation Manifestations of intracranial hypertension 
iricludp bulging fontanelles headaches and bilateral papilledema Chronic 
corricosreroid theraov mav interfere with the orowh and develooment of children 
sutyects involved in the studies 
The following locdl adverse reactions are reported infrequently when topical 
corricori?roids are used as recommended These reactions are listed in 
approximate decreasing order of occurrence burning itching irritation dryness 
tolliculiris hypertrichosis acrieilorm eruptions hypopigmenration perioral 
dermatitis allergic Lontact dermatitis maceration of the skin secondary infection 
skiri atrophy striae miliaria 
OVERDOSAGE Topically applied corticosteroids can be absorbed in suffrclent 
amounii to produce systemic effects (See PRECAUTIONS J 
DOSAGE AND ADMINISTRATION Apply a thin film of DIPROLENE AF 
Cream to the affected skin areas once or twice daily Treatment with D I P R O W  
AF Cream should be limited to 459 Der week 
DIPROLENE AF Cream Is not to be used wlth occlurlve dressln s. 
HOW SUPPLIED DIPROLENE AF Cream 0 05% is supplied in 15 (NDC 00% 
Store between 2' and 30°C (36' and 86"FJ. 
051 I 01) and 45 gram (NDC 0085 051 7 02) tubes boxes of one 
9/81  14044302BS 
Scheririy Corporation 
Kenilworth. NJ 07033 UYI 
Topical Tretinoin Improves Photoaged Skin. 
Weiss, et al. JAMA 259527432,  1988. 
JS 
This original contribution compared topical treti- 
noin and vehicle cream in 30 patients over a 16- 
week period (originally 40 patients were enrolled). 
Treatment sites included dorsal forearms (dorsum 
of the hands) and the face. Forearm skin improve- 
ment was often graded as superior to that of facial 
skin with fine wrinkles improved in both locations. 
Dermatitis was reported as an adverse reaction in 
92% of patients, 11 patients required potent topical 
steroids and 3 patients (7.5% of the original 40 pa- 
tients) withdrew as a result of the dermatitis. 
As this article received widespread lay press re- 
view, it is a study of importance with other related 
protocols sure to follow. 
HUBERT T. GREENWAY, J R . ,  M.D. 
Melanoma with Metastasis to Regional or Inguinal 
Lymph Nodes. SE Singletary, et al. South Med J 
815-9, 1988. 
A retrospective analysis over a 30-year interval at 
M.D. Anderson Hospital revealed 714 patients with 
melanoma who underwent node dissection for his- 
tologically positive nodes. Survival rates calculated 
from the date of node dissection were 33% (5 year) 
and 28% (10 year). The major prognostic factor sur- 
vival was the number of positive nodes. Age, sex, 
race, location of the primary (except on the calf), 
immediate vs delayed node dissection, and adju- 
vant therapy were all factors unrelated to survival 
after the development of regional node disease. 
HUBERT T. GREENWAY, JR., M.D. 
Natural Interferon Alfa for Treatment of Condy- 
lomata Acuminata. AE Friedman-Kien, et al. 
JAMA 259533438,  1988. 
Natural (leukocyte) interferon alfa was given twice 
weekly for up to 8 weeks for the treatment of con- 
dyloma acuminata (double blind, placebo con- 
trolled 72 patients) in 86 patients. Most of the pa- 
tients (>85%) had received previous therapy for 
their lesions. Treatment completely eliminated 
warts in 62% of patients (compared with 21% of 
placebo controls). This study indicates longer treat- 
ment regimens (than in other recent studies) may 
provide improved results in these patients. 
HUBERT T. GREENWAY, JR. ,  M.D. 
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